NCT02639442View on ClinicalTrials.gov

Clinical Study for the Evaluation of the Safety and Initial Performance of the ClearRing System for the Treatment of Benign Prostatic Hyperplasia

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

May 31, 2019

Conditions
Benign ProstaticHyperplasia (BPH)
Interventions
DEVICE

ClearRing™

Trial Locations (2)

Unknown

Rambam MC, Haifa

Department of Urology, Pauls Stradins Clinical University Hospital, Riga

Sponsors

Lead Sponsor

ProArc Medical
All Listed Sponsors
lead

ProArc Medical

INDUSTRY

NCT02639442 - Clinical Study for the Evaluation of the Safety and Initial Performance of the ClearRing System for the Treatment of Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter